Exane Derivatives’s Tanger SKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20
Closed -$477 725
2018
Q2
$477 Hold
20
﹤0.01% 567
2018
Q1
$452 Buy
+20
New +$469 ﹤0.01% 512
2017
Q4
Sell
-1
Closed -$24 634
2017
Q3
$24 Sell
1
-9
-90% -$228 ﹤0.01% 555
2017
Q2
$260 Hold
10
﹤0.01% 527
2017
Q1
$328 Sell
10
-19,728
-100% -$668K ﹤0.01% 447
2016
Q4
$706K Buy
19,738
+365
+2% +$12.9K 0.14% 128
2016
Q3
$755K Buy
19,373
+8,555
+79% +$346K 0.11% 124
2016
Q2
$435K Buy
+10,818
New +$394K 0.07% 141

Other funds holding SKT

Exane Derivatives's SKT Position: Q3 2018 in Review

Exane Derivatives sold out of Tanger (SKT) in Q3 2018, closing a stake of 20 shares — an estimated $477 sold.

Exane Derivatives first reported a position in SKT in Q2 2016 and held it in 8 quarters. The position peaked at $755K in Q3 2016. 268 funds tracked by Wall St. Rank hold SKT as of Q3 2018.

  • Exane Derivatives reported no remaining Tanger position as of Q3 2018 after selling out during the quarter.
  • Exane Derivatives sold 20 Tanger shares in Q3 2018, an estimated $477.
  • Exane Derivatives first reported a position in Tanger in Q2 2016 and held it in 8 quarters.
  • Exane Derivatives's Tanger position peaked at $755K in Q3 2016.
  • 268 funds tracked by Wall St. Rank held Tanger as of Q3 2018.

Based on Exane Derivatives's 13F filing for Q3 2018, filed 24 Oct 2018.